FREE US SHIPPING on orders $100+
Same-day dispatch
Bulk pack pricing available
COA available on request
Discreet packaging · Card, Apple Pay & Samsung Pay accepted
FREE US SHIPPING on orders $100+
Same-day dispatch
Bulk pack pricing available
COA available on request
Discreet packaging · Card, Apple Pay & Samsung Pay accepted
Sign In / Create Account
  • The Science
  • About
  • Contact
  • BPC-157: Mechanism, Literature & Reference Protocols

    Last updated August 8, 2026 · Reviewed for research accuracy by the MarquePeptides technical team.

    What Is BPC-157?

    BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a 15-amino-acid sequence — derived from a fragment of a protein naturally found in human gastric juice. It has become one of the most widely studied research peptides in tissue-repair and gastrointestinal pathway literature over the past two decades.

    Research context only: This article summarizes published laboratory and animal-model research. It is not a guide to human use, dosing, or administration. BPC-157 is sold by MarquePeptides strictly for research use only.

    Mechanism of Action in Research Literature

    Published research on BPC-157 has focused primarily on its interaction with angiogenic signaling pathways and its effects in gastrointestinal tissue-repair animal models. Sikiric et al. (2011) characterized its “stable gastric pentadecapeptide” properties across a range of GI-tract injury models. Later work by Seiwerth et al. (2018) examined its interaction with standard angiogenic growth factor pathways, proposing a role in modulating the VEGF and other growth-factor signaling cascades studied in wound-healing research.

    Because BPC-157 is a synthetic fragment rather than a full native protein, in vitro receptor-binding studies remain an active area of ongoing characterization — much of the published literature to date relies on animal models and functional outcome studies rather than fully mapped receptor pharmacology.

    Molecular Specifications

    Property Value
    CAS Number 137525-51-0
    Molecular Formula C₂₂H₉₈N₁₆O₂₂
    Molecular Weight 1419.53 g/mol
    Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

    Full batch-specific purity data and COA are available on the BPC-157 product page.

    Laboratory Handling Reference

    Like most lyophilized research peptides, BPC-157 should be stored at −20°C prior to reconstitution and used within the stability window noted on its batch COA once reconstituted with bacteriostatic water. See our companion guide, Reconstitution & Storage: A Reference Guide for Research Peptides, for full handling protocols applicable across the catalog.

    References

    • Sikiric P, et al. “Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract.” Curr Pharm Des. 2011;17(16):1612-1632.
    • Seiwerth S, et al. “BPC 157 and Standard Angiogenic Growth Factors.” Curr Pharm Des. 2018;24(18):1972-1989.

    References provided for research context only. Products sold by MarquePeptides are For Research Use Only — not for human consumption.

    MP
    MarquePeptides Technical Team
    Research & Compliance Review